dr. lynce on fda approval of atezolizumab/nab-paclitaxel in tnbc
Published 4 years ago • 158 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
1:17
dr. hamilton on fda approval of atezolizumab/nab-paclitaxel in tnbc
-
0:13
copy of dr. hamilton on fda approval of atezolizumab/nab-paclitaxel in tnbc
-
2:38
dr. mittendorf highlights fda approval of atezolizumab/nab-paclitaxel in pd-l1 tnbc
-
1:48
dr. saeed rafii on atezolizumab/ nab-paclitaxel in tnbc
-
7:08
impassion130: results of atezolizumab plus nab-paclitaxel for frontline tnbc
-
1:27
fda approval of atezolizumab for nsclc
-
5:45
case 3: atezolizumab/nab-paclitaxel for triple negative breast cancer
-
3:12
atezolizumab with nab-paclitaxel improves survival in breast cancer patients
-
1:03
dr. kalinsky on clinical impact of atezolizumab combo in tnbc
-
1:50
dr lynce on ongoing trials evaluating novel combinations in inflammatory breast cancer
-
5:59
impassion130: atezolizumab and nab-paclitaxel in triple-negative breast cancer
-
4:15
impassion130: atezolizumab (atezo) nab-paclitaxel (nab-p) vs placebo nab-p in treatment-naiv...
-
1:25
dr. lynce on remaining questions with parp inhibitors in breast cancer
-
3:16
survival with atezolizumab and nab-paclitaxel versus nab-paclitaxel alone among patients with advanc
-
4:45
atezolizumab plus nab-paclitaxel for advanced triple negative breast cancer
-
1:01
the role of nab-paclitaxel in treating tnbc
-
0:38
dr. petrylak on fda approval of pembrolizumab in bladder cancer
-
0:35
dr. farago on the fda approval of pembrolizumab for lower pd-1 cutoff nsclc
-
8:42
chemoimmunotherapy in tnbc: the impassion130 trial